Ironwood Pharmaceuticals (IRWD) Operating Income (2010 - 2026)
Ironwood Pharmaceuticals (IRWD) posted Operating Income of $72.6 million for Q1 2026, up 966.47% sequentially from $6.8 million in Q4 2025, and up 349.32% YoY from $16.2 million in Q1 2025.
Ironwood Pharmaceuticals (IRWD) Operating Income (2010 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has reported Operating Income for 17 years, with the latest figure at $72.6 million in Q1 2026.
- Quarterly Operating Income rose 349.32% year-over-year to $72.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $200.2 million (up 277.73% YoY) and the FY2025 annual result came in at $98.5 million, up 5.78% from the prior year.
- Operating Income rose to $72.6 million in Q1 2026 per IRWD's latest filing, from $6.8 million in the prior quarter.
- Over five years, Operating Income peaked at $75.5 million in Q3 2025 and troughed at -$1.1 billion in Q2 2023.
- A 5-year average of -$25.3 million and a median of $40.0 million in 2023 frame the typical range for Operating Income.
- The sharpest annual moves came in 2023 and 2026: Operating Income tumbled 2046.17% in 2023, then surged 349.32% in 2026.
- Over 5 years, Operating Income stood at $68.4 million in 2022, then slumped by 45.02% to $37.6 million in 2023, then dropped by 16.22% to $31.5 million in 2024, then tumbled by 78.39% to $6.8 million in 2025, then soared by 966.47% to $72.6 million in 2026.
- According to Business Quant data, Operating Income over the past three periods registered $72.6 million, $6.8 million, and $75.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Ironwood Pharmaceuticals | 689.68 Mn | 610.55 Mn | - | 79.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 79.31 Mn |
| Mar 31, 2026 | 72.57 Mn |
| Dec 31, 2025 | 6.81 Mn |
| Sep 30, 2025 | 75.48 Mn |
| Jun 30, 2025 | 45.32 Mn |
| Mar 31, 2025 | -29.11 Mn |
| Dec 31, 2024 | 31.49 Mn |
| Sep 30, 2024 | 25.64 Mn |
| Jun 30, 2024 | 24.98 Mn |
| Mar 31, 2024 | 11.02 Mn |
| Dec 31, 2023 | 37.59 Mn |
| Sep 30, 2023 | 40.02 Mn |
| Jun 30, 2023 | -1.08 Bn |
| Mar 31, 2023 | 60.10 Mn |
| Dec 31, 2022 | 68.36 Mn |
| Sep 30, 2022 | 68.47 Mn |
| Jun 30, 2022 | 55.66 Mn |
| Mar 31, 2022 | 57.85 Mn |
| Dec 31, 2021 | 56.59 Mn |
| Sep 30, 2021 | 65.17 Mn |